MedPath

安徽省双科药业有限公司

Ownership
-
Established
2000-12-11
Employees
-
Market Cap
-
Website
www.anhuishuangke.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:8

Drug Approvals

Bendazac lysine

Product Name
苄达赖氨酸
Approval Number
国药准字H20058612
Approval Date
Jul 22, 2020
NMPA

Tropicamide Eye Drops

Product Name
托吡卡胺滴眼液
Approval Number
国药准字H20046248
Approval Date
Jun 19, 2020
NMPA

Timolol Maleate Eye Drops

Product Name
马来酸噻吗洛尔滴眼液
Approval Number
国药准字H20045418
Approval Date
Jun 19, 2020
NMPA

Nateglinide

Approval Number
国药准字H20061130
Approval Date
Sep 6, 2011
NMPA

Telmisartan

Product Name
替米沙坦
Approval Number
国药准字H20051762
Approval Date
Nov 29, 2010
NMPA

Pazufloxacin Mesilate

Product Name
甲磺酸帕珠沙星
Approval Number
国药准字H20051835
Approval Date
Nov 29, 2010
NMPA

Pemirolast Potassium

Product Name
吡嘧司特钾
Approval Number
国药准字H20051430
Approval Date
Nov 29, 2010
NMPA

Dexamethasone Sodium Phosphate Eye Drops

Product Name
地塞米松磷酸钠滴眼液
Approval Number
国药准字H20057187
Approval Date
Aug 24, 2005
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.